Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Margarita Revelo"'
Autor:
Fabiola Quinteros Hinojosa, Margarita Revelo, Alexander Salazar, Genaro Maggi, Renato Schiraldi, Nicolas Brogly, Fernando Gilsanz
Publikováno v:
Brazilian Journal of Anesthesiology, Vol 67, Iss 1, Pp 89-91 (2017)
Inotropic drugs are part of the treatment of heart failure; however, inotropic treatment has been largely debated due to the increased incidence of adverse effects and increased mortality. Recently levosimendan, an inotropic positive agent, has been
Externí odkaz:
https://doaj.org/article/ceeecc211b25475faa36810d31e26eb2
Autor:
Fabiola Quinteros Hinojosa, Margarita Revelo, Alexander Salazar, Genaro Maggi, Renato Schiraldi, Nicolas Brogly, Fernando Gilsanz
Publikováno v:
Revista Brasileira de Anestesiologia, Vol 67, Iss 1, Pp 89-91
Abstract Inotropic drugs are part of the treatment of heart failure; however, inotropic treatment has been largely debated due to the increased incidence of adverse effects and increased mortality. Recently levosimendan, an inotropic positive agent,
Externí odkaz:
https://doaj.org/article/f61e1c92b4db425f9d82dc6f5060531b
Autor:
Nicolas Brogly, Fernando Gilsanz, R. Schiraldi, G. Maggi, Alexander Salazar, Fabiola Quinteros Hinojosa, Margarita Revelo
Publikováno v:
Brazilian Journal of Anesthesiology, Vol 67, Iss 1, Pp 89-91 (2017)
Revista Brasileira de Anestesiologia, Vol 67, Iss 1, Pp 89-91
Revista Brasileira de Anestesiologia, Vol 67, Iss 1, Pp 89-91
Inotropic drugs are part of the treatment of heart failure; however, inotropic treatment has been largely debated due to the increased incidence of adverse effects and increased mortality. Recently levosimendan, an inotropic positive agent, has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0e7e96f27d7566a381f0fca88f9f0d3
Autor:
Nicolas Brogly, Alexander Salazar, R. Schiraldi, Margarita Revelo, G. Maggi, Fernando Gilsanz, Fabiola Quinteros Hinojosa
Publikováno v:
Brazilian Journal of Anesthesiology. 67:89-91
ResumoFármacos inotrópicos fazem parte do tratamento de insuficiência cardíaca; no entanto, o tratamento com inotrópicos tem sido amplamente debatido devido ao aumento da incidência de efeitos adversos e da mortalidade. Recentemente, levosimend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d94bb7d8238f27ac52a1ba97690beec1
https://doi.org/10.1016/j.bjan.2014.07.008
https://doi.org/10.1016/j.bjan.2014.07.008